View Older Stories View More Recent Stories
-
Form 13F-HR DEERFIELD MANAGEMENT For: Sep 30
-
Form 4 AdaptHealth Corp. For: Nov 08 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Chemical & Engineering News Names Frontier Medicines One of its 10 Chemistry Start-Ups to Watch
-
DFB Healthcare Acquisitions Corp. Announces Closing of Business Combination With AdaptHealth Holdings LLC
-
DFB Healthcare Acquisitions Corp. Announces Stockholder Approval of Business Combination With AdaptHealth Holdings, LLC
-
Dracen Pharmaceuticals announces DRP-104 presentations at the 2019 Society of Immunotherapy of Cancer (SITC) Meeting
-
Donald A. Deieso, Ph.D., WCG (WIRB-Copernicus Group), Lewis C. Cantley, Ph.D., Weill Cornell Medicine & NewYork-Presbyterian Hospital, And Vanessa Bayer, Actress, Writer And Comedian, To Be Honore
-
DFB Healthcare Acquisitions Corp. and AdaptHealth Holdings LLC Announce Amendments to Merger and Subscription Agreements
-
DFB Healthcare Acquisitions Corp. Announces Record Date for Special Meeting of Shareholders
-
SHINE closes $50-million financing with Oaktree to support execution of construction and commercialization plans
-
NewLink Genetics (NLNK) and Lumos Pharma Enter Merger Agreement
-
NewLink Genetics and Lumos Pharma Enter into Merger Agreement to Form Biopharmaceutical Company Focused on Developing Therapies to Treat Rare Diseases
-
NewLink Genetics and Lumos Pharma Enter into Merger Agreement to Form Biopharmaceutical Company Focused on Developing Therapies to Treat Rare Diseases
-
MATTER to Open in New York City as Part of New Life Sciences Campus
-
Deerfield Management Brings Together Scientists, Entrepreneurs and Leading Companies to Form the New York-Based Healthcare Innovation Campus
-
NYCEDC and Deerfield Management Partner to Create a Life Sciences Campus -- MATTER to Create LifeSci NYC's Newest Incubator
-
Nkarta Therapeutics Named as a “Fierce 15” Biotechnology Company of 2019
-
FierceBiotech names Frontier Medicines one of its "Fierce 15" biotech companies of 2019
-
Nkarta Therapeutics Promotes Nadir Mahmood, Ph.D., to Chief Business Officer
-
Edgewise Therapeutics Closes $50 Million Series B Financing
-
Nkarta Therapeutics Appoints Vice President of Regulatory Affairs
-
KemPharm (KMPH) Enters Definitive Collaboration and License Agreement for its ADHD Candidates with Affiliate of Gurnet Point Capital
-
KemPharm Announces Entry into Definitive Collaboration and License Agreement for its ADHD Candidates, KP415 and KP484, with an Affiliate of Gurnet Point Capital
-
Nkarta Therapeutics Raises $114 Million in Series B Financing to Advance Multiple Programs into Clinical Trials
-
Oncorus Announces $79.5 Million Series B Financing Co-Led by Cowen Healthcare Investments and Perceptive Advisors
-
Graybug Vision Secures $80 million of Additional Funding to Advance its Potentially Transformative Retina and Glaucoma Clinical Programs
-
Form 13F-HR DEERFIELD MANAGEMENT For: Jun 30
-
Nuvo Pharmaceuticals™ Announces 2019 Second Quarter Results
-
Frontier Medicines Announces Three Executive Hires: Chief Scientific Officer, Chief Technology Officer & Head of Degrader Technologies
-
Nuvo Pharmaceuticals™ Provides VIMOVO Patent Update
-
Frequency Therapeutics Completes $62 Million Series C Financing
-
Acutus Medical Announces Addition of Scott Huennekens as Executive Chairman of the Board
-
REVOLUTION Medicines Closes $100 Million Financing to Advance Pipeline of Novel Therapies Addressing Frontier Targets in RAS-Dependent Cancers
-
AdaptHealth to Become a Public Company via Business Combination With DFB Healthcare
-
Nuvo Pharmaceuticals™ Announces Director Election Results of its Annual General Meeting and Updates to the Facility Agreement with Deerfield
-
Frontier Medicines launches with $67 million to develop novel medicines that drug the "undruggable" targets driving human disease
-
Acutus Medical Announces $170 Million in Financing
-
Nuvo Pharmaceuticals™ Provides Corporate Update
-
Columbia University and Deerfield Management Launch Hudson Heights Innovations
-
Duchenne Muscular Dystrophy Prevalence Increases, While Incidence Remains Steady
-
Schrödinger Announces Close of Latest Financing, Raising Total of $110 Million
-
Form 13F-HR DEERFIELD MANAGEMENT For: Mar 31
-
Nuvo Pharmaceuticals™ Announces 2019 First Quarter Results
-
Aerie Pharmaceuticals Announces Additional Undrawn $100M Credit Facility with Deerfield Management, Increasing Availability to $200M
-
NeoChord Raises Additional Financing to Drive Catheter-based Program Development, Bringing Total Series D Funding to over $32 Million
-
NeoChord Raises Additional Financing to Drive Catheter-based Program Development, Bringing Total Series D Funding to over $32 Million
-
UIC and Deerfield Management launch West Loop Innovations to foster development of new therapeutics
-
Mirum Pharmaceuticals Presents New Data Demonstrating Durable Improvements in Clinical Outcome Measures in Patients with PFIC2 and Alagille Syndrome Treated with Maralixibat
-
Vinson & Elkins Makes Significant Expansion in New York With Addition of Nationally Recognized Real Estate Team
-
Nuvo Pharmaceuticals™ Announces 2018 Fourth Quarter and Year-End Results

